| (210) | Number of the EPO application | 16808374 |
| (220) | Filing date of the EPO application | 2016.06.10 |
| (80) | EPO patent specification publication (B) | EPB nr. 37/2023, 2023.09.13 |
| (110) | EPO patent number | 3307271 |
| (11) | Number of the document | MD 3307271 T2 |
| (21) | Number of the application | e 2018 0393 |
| (71) | Name(s) of applicant(s), code of the country | AGIOS PHARMACEUTICALS, INC., US; |
| (72) | Name(s) of inventor(s), code of the country | AGRESTA Samuel V., US;
CHEN Yue, US;
COHEN Marvin Barry, US;
DANG Leonard Luan C., US;
KUNG Charles, US;
MERICA Elizabeth A., US;
SILVER Bruce Alan, US;
YANG Hua, US; |
| (73) | Name(s) of owner(s), code of the country | AGIOS PHARMACEUTICALS INC., US; |
| (54) | Title of the invention | Methods of using pyruvate kinase activators |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 31/4709 (2006.01.01); A61K 31/496 (2006.01.01); C07D 215/36 (2006.01.01); A61P 7/06 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.06.30 |
| (49) | Date of publication of the translation of the validated European patent specification | 2024.01.31 |
| (30) | Priority | 201562174216 P, 2015.06.11, US |
| (74) | Patent attorney | (Procedură) SOCOLOVA Sofia, Str. Drumul Viilor nr. 42, bloc 3, ap. 60, MD-2021, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2016/036893, 2016.06.10 |
| (87) | International publication | WO 2016/201227, 2016.12.15 |